Search research articles
Contact Us
Filters
Showing results (131-140 of 186) with videos related to
Page
of 19
Sort By:
Oncogene
|
May 26, 2022
Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets
Alberto Puccini, Kelsey Poorman, Fabio Catalano, et al.
Pharmacogenetics and Genomics
|
December 15, 2015
Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)
Adam M Lee, Qian Shi, Steven R Alberts, et al.
JCO Precision Oncology
|
August 11, 2022
Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial
Frank A Sinicrope, Qian Shi, Aurelie Catteau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 22, 2008
Recommendations on the use of 18F-FDG PET in oncology
James W Fletcher, Benjamin Djulbegovic, Heloisa P Soares, et al.
Molecular Cancer Therapeutics
|
October 10, 2020
Molecular Characterization of Appendiceal Goblet Cell Carcinoid
Hiroyuki Arai, Yasmine Baca, Francesca Battaglin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 19, 2017
Immune Modulation Therapy and Imaging: Workshop Report
Anthony F Shields, Paula M Jacobs, Mario Sznol, et al.
Molecular Cancer Therapeutics
|
November 2, 2021
Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers
Michael Cerniglia, Joanne Xiu, Axel Grothey, et al.
Journal of the National Cancer Institute
|
September 25, 2025
Sex differences in chemotherapy completion, toxicities, and survival in colon cancer: an analysis of 2201 patients from CALGB/SWOG 80702 (Alliance)
En Cheng, Qian Shi, Anthony F Shields, et al.
NPJ Precision Oncology
|
February 26, 2026
Clinical and molecular characteristics of Class II and III BRAF mutations in colorectal cancer
Ibrahim Halil Sahin, Joanne Xiu, Yasmine Baca, et al.
Cancer Research Communications
|
May 16, 2022
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers
Husain Yar Khan, Misako Nagasaka, Yiwei Li, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 186) with videos related to
Sort By:
Page
of 19
Oncogene
|
May 26, 2022
Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets
Alberto Puccini, Kelsey Poorman, Fabio Catalano, et al.
Pharmacogenetics and Genomics
|
December 15, 2015
Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)
Adam M Lee, Qian Shi, Steven R Alberts, et al.
JCO Precision Oncology
|
August 11, 2022
Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial
Frank A Sinicrope, Qian Shi, Aurelie Catteau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 22, 2008
Recommendations on the use of 18F-FDG PET in oncology
James W Fletcher, Benjamin Djulbegovic, Heloisa P Soares, et al.
Molecular Cancer Therapeutics
|
October 10, 2020
Molecular Characterization of Appendiceal Goblet Cell Carcinoid
Hiroyuki Arai, Yasmine Baca, Francesca Battaglin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 19, 2017
Immune Modulation Therapy and Imaging: Workshop Report
Anthony F Shields, Paula M Jacobs, Mario Sznol, et al.
Molecular Cancer Therapeutics
|
November 2, 2021
Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers
Michael Cerniglia, Joanne Xiu, Axel Grothey, et al.
Journal of the National Cancer Institute
|
September 25, 2025
Sex differences in chemotherapy completion, toxicities, and survival in colon cancer: an analysis of 2201 patients from CALGB/SWOG 80702 (Alliance)
En Cheng, Qian Shi, Anthony F Shields, et al.
NPJ Precision Oncology
|
February 26, 2026
Clinical and molecular characteristics of Class II and III BRAF mutations in colorectal cancer
Ibrahim Halil Sahin, Joanne Xiu, Yasmine Baca, et al.
Cancer Research Communications
|
May 16, 2022
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers
Husain Yar Khan, Misako Nagasaka, Yiwei Li, et al.
Page
of 19